Advertisement

Topics

Provista Diagnostics, Inc. Company Profile

14:00 EDT 25th June 2018 | BioPortfolio

Provista Diagnostics, Inc., a Delaware company, develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. The company's focus is on oncology-related diagnostics where a significantly high, unmet clinical need for such testing products exists. Near term development and commercialization efforts focus on women's cancers such as breast and ovarian cancer.

Provista Diagnostic's technologies are developed at our CLIA accredited, GLP compliant, 13,610 sq/ft laboratory facility based in Scottsdale, Arizona. Recently, Provista has formed corporate headquarters in New York to take advantage of the sales, marketing, regulatory and financial expertise in the northeast US.

Contact Details

Provista Diagnostics, Inc.
17301 North Perimeter Drive,
Scottsdale, AZ 85255
Tel: 1(602) 224 5500
Fax: 1(602) 391 2101

Investor Inquiries

David R. Holmes
Tel: 1(917) 720 6602
HolmesD@provistadx.com

Media Inquiries

Tel: 1(917) 551 6960
info@provistadx.com


News Articles [348 Associated News Articles listed on BioPortfolio]

Provista Launches One-Stop Web Destination For Industry News, Features And Information

IRVING, Texas , Oct. 6, 2017 /-  Provista, a proven leader in the supply chain industry with more than $100 billion in purchasing power, today announced a new resource area on Provistaco.com fe...

Emosis, 5─Diagnostics ink exclusive distribution deal for Emo─test, HIT Confirm, in CE Mark─regulated countries

Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5─Diagnostics (5─D), a worldwide distributor for haemostasis products and in─vitro diagnos...

Carbapenemase Diagnostics Market 20172022: Test Volume and Sales Forecasts by CountryUS, Europe, Japan [Report Updated: 15012018] Prices from USD $950

This report presents test volumes and sale forecasts for the US, Europe France, Germany, Italy, Spain, UK and Japan. List of TablesFrance Carbapenemase Test Volume and Diagnostics Sales ForecastGerma...

BNP Test Volume and Sales Forecasts 20172022: US, Europe, Japan [Report Updated: 15012018] Prices from USD $750

This new report from VPGMarketResearch provides analysis of BNP testing, including test volume and sales forecasts by country. Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USAList of T...

DOD taps Ortho Clinical Diagnostics for $9.8M surgical products contract

In-vitro diagnostics company Ortho Clinical Diagnostics was awarded a contract worth up to approximately $9.8 million from th -More- 

Quotidian Technical Highlights on Selected Medical Equipment Stocks -- GenMark Diagnostics, ...

www.wallstequities.com/registration GenMark Diagnostics Carlsbad, Californiaheadquartered GenMark Diagnostics Inc.'s shares recorded a trading volume of 333,899 shares last Friday. The stock finis...

More Bad Legal News for Athena Diagnostics: Don’t Mess with Mayo

We have been reporting for more than a year about the case of Williams v. Quest Diagnostics (the parent company of Athena Diagnostics), in which the plaintiff has sued Athena and Quest for causing the...

MIP Diagnostics secures £1.5m investment for synthetic antibodies

Life sciences company MIP Diagnostics has closed a Series A financing round, in which it raised £1.5 million for its...Read More... The post MIP Diagnostics secures £1.5m investment for synthetic an...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [194 Associated PubMed Articles listed on BioPortfolio]

Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

The importance of medical imaging in the diagnosis and monitoring of cancer cannot be overstated. As personalized cancer treatments are gaining popularity, a need for more advanced imaging techniques ...

A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis.

To assess a new and highly specific, but low-cost, easily performed and suitable for large-scale applications method for renal fibrosis (RF) diagnostics.

Nucleic acid diagnostic approaches in parasitology.

Nucleic acid diagnostic technologies are partly replacing traditional microscopy and antigen detection methods in parasitological diagnostics. In particular, the diagnostics of parasitic diarrhea is u...

Is bronchoscopy always justified in diagnosis of haemoptysis?

Fiber-optic bronchoscopy (FOB) is commonly performed in the first line in diagnostic process of haemoptysis. However, lots of evidences suggest that in haemoptysis FOB do not always provide additional...

Molecular allergy diagnostics refines characterization of children sensitized to dog dander.

Sensitization to dog dander is an important risk factor for rhino-conjunctivitis and asthma, but not sufficient for diagnosing dog allergy. Molecular allergy diagnostics offers new opportunities for r...

Clinical Trials [198 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Companies [922 Associated Companies listed on BioPortfolio]

Provista Diagnostics, Inc.

Provista Diagnostics, Inc., a Delaware company, develops and commercializes breakthrough, easy to administer blood-based diagnostic tests for early oncology-related disease state recognition and det...

Provista and National Intergovernmental Purchasing Alliance Company

National Intergovernmental Purchasing Alliance Company (National IPA) is a cooperative purchasing organization established for public agencies across the United States with the sp...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Cleveland Diagnostics, Inc.

Cleveland Diagnostics, Inc., is a clinical-stage biotechnology company developing technology to improve cancer diagnostics. Its Solvent Interaction Analysis (SIA) technology inves...

More Information about "Provista Diagnostics, Inc." on BioPortfolio

We have published hundreds of Provista Diagnostics, Inc. news stories on BioPortfolio along with dozens of Provista Diagnostics, Inc. Clinical Trials and PubMed Articles about Provista Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Provista Diagnostics, Inc. Companies in our database. You can also find out about relevant Provista Diagnostics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...


Corporate Database Quicklinks



Searches Linking to this Company Record